FTC Challenges $28B Amgen-Horizon Therapeutics Merger

By Bryan Koenig and Al Barbarino · May 16, 2023, 11:05 AM EDT

The Federal Trade Commission on Tuesday sought to shut down U.S. biotechnology company Amgen Inc.'s proposed $27.8 billion purchase of Ireland-based drugmaker Horizon Therapeutics PLC, filing a lawsuit in federal court...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

Federal Trade Commission V. Amgen Inc., et al.

Case Number

1:23-cv-03053

Court

Illinois Northern

Nature of Suit

410(Anti-Trust)

Date Filed

May 16, 2023